Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3376 AL 3390

Polymorphisms and Pharmacogenomics of NQO2: The Past and the Future

Janda E, Boutin JA, De Lorenzo C, Arbitrio M.

Genes (Basel). 2024 Jan 10;15(1):87. doi: 10.3390/genes15010087.

The Overtreatment Trap: Navigating Dopamine Dysregulation Syndrome in Parkinson's Disease

Sant Bakshsingh V, Sequeira R.

Cureus. 2024 Sep 30;16(9):e70500. doi: 10.7759/cureus.70500. eCollection 2024 Sep.

No trend to rising rates: A review of Parkinson's prevalence studies in the United Kingdom

Varden R, Walker R, O'Callaghan A.

Parkinsonism Relat Disord. 2024 Nov;128:107015. doi: 10.1016/j.parkreldis.2024.107015. Epub 2024 May 20.

Machine learning based algorithms for virtual early detection and screening of neurodegenerative and neurocognitive disorders: a systematic-review

Yousefi M, Akhbari M, Mohamadi Z, Karami S, Dasoomi H, Atabi A, Sarkeshikian SA, Abdoullahi Dehaki M, Bayati H, Mashayekhi N, Varmazyar S, Rahimian Z, Asadi Anar M, Shafiei D, Mohebbi A.

Front Neurol. 2024 Dec 9;15:1413071. doi: 10.3389/fneur.2024.1413071. eCollection 2024.

Breaking barriers in Parkinson's care: the multidisciplinary team approach

Pirtošek Z.

J Neural Transm (Vienna). 2024 Nov;131(11):1349-1361. doi: 10.1007/s00702-024-02843-6. Epub 2024 Oct 17.

The impact of psychiatric comorbidity on Parkinson's disease outcomes: a systematic review and meta-analysis

Burchill E, Watson CJ, Fanshawe JB, Badenoch JB, Rengasamy E, Ghanem DA, Holle C, Conti I, Sadeq MA, Saini A, Lahmar A, Cross B, McGuigan G, Nandrha A, Kane EJ, Wozniak J, Farouk Ghorab RM, Song J, Sommerlad A, Lees A, Zandi MS, David AS, Lewis G, Carter B, Rogers JP.

Lancet Reg Health Eur. 2024 Feb 9;39:100870. doi: 10.1016/j.lanepe.2024.100870. eCollection 2024 Apr.

Devices used for photobiomodulation of the brain-a comprehensive and systematic review

Fernandes F, Oliveira S, Monteiro F, Gasik M, Silva FS, Sousa N, Carvalho Ó, Catarino SO.

J Neuroeng Rehabil. 2024 Apr 10;21(1):53. doi: 10.1186/s12984-024-01351-8.

Poetry-writing and suicide attempt following bilateral subthalamic nucleus stimulation in a patient with Parkinson's disease

Chen YC, Lin CY, Lee YT, Hong CT.

J Formos Med Assoc. 2024 Jun;123(6):727-728. doi: 10.1016/j.jfma.2023.10.001. Epub 2023 Oct 30.

The role of orexin in Parkinson's disease

Braun A, Manavis J, Yamanaka A, Ootsuka Y, Blumbergs P, Bobrovskaya L.

J Neurosci Res. 2024 Mar;102(3):e25322. doi: 10.1002/jnr.25322.

Accelerating Parkinson's Disease drug development with federated learning approaches

Khanna A, Adams J, Antoniades C, Bloem BR, Carroll C, Cedarbaum J, Cosman J, Dexter DT, Dockendorf MF, Edgerton J, Gaetano L, Goikoetxea E, Hill D, Horak F, Izmailova ES, Kangarloo T, Katabi D, Kopil C, Lindemann M, Mammen J, Marek K, McFarthing K, Mirelman A, Muller M, Pagano G, Peterschmitt MJ, Ren J, Rochester L, Sardar S, Siderowf A, Simuni T, Stephenson D, Swanson-Fischer C, Wagner JA, Jones GB.

NPJ Parkinsons Dis. 2024 Nov 21;10(1):225. doi: 10.1038/s41531-024-00837-5.

GenoTools: An Open-Source Python Package for Efficient Genotype Data Quality Control and Analysis

Vitale D, Koretsky M, Kuznetsov N, Hong S, Martin J, James M, Makarious MB, Leonard H, Iwaki H, Faghri F, Blauwendraat C, Singleton AB, Song Y, Levine K, Sreelatha AAK, Fang ZH, Nalls M.

bioRxiv [Preprint]. 2024 Jul 3:2024.03.26.586362. doi: 10.1101/2024.03.26.586362.

miRNA family miR-29 inhibits PINK1-PRKN dependent mitophagy via ATG9A

Markham BN, Ramnarine C, Kim S, Grever WE, Soto-Beasley AI, Heckman M, Ren Y, Osborne AC, Bhagwate AV, Liu Y, Wang C, Kim J, Wszolek ZK, Ross OA, Springer W, Fiesel FC.

bioRxiv [Preprint]. 2024 Jan 19:2024.01.17.576122. doi: 10.1101/2024.01.17.576122.

Combining Biomarkers with Genetics In Prodromal/Earliest Phase Parkinson's Disease

Seibler P, Streubel-Gallasch L, Klein C.

J Parkinsons Dis. 2024;14(s2):S345-S351. doi: 10.3233/JPD-240155.

Common genetic risk for Parkinson's disease and dysfunction of the endo-lysosomal system

Bhore N, Bogacki EC, O'Callaghan B, Plun-Favreau H, Lewis PA, Herbst S.

Philos Trans R Soc Lond B Biol Sci. 2024 Apr 8;379(1899):20220517. doi: 10.1098/rstb.2022.0517. Epub 2024 Feb 19.

Evaluating pimavanserin tartrate as a treatment in Parkinson's disease

Müller T.

Expert Opin Pharmacother. 2024 Oct;25(15):1999-2003. doi: 10.1080/14656566.2024.2417733. Epub 2024 Oct 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias